Listed

Kraig Biocraft Laboratories, Inc.: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Mar 12, 2021 and accepted by EDGAR at Mar 12, 2021, 16:35 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2020-01-01 to 2020-12-31$88.5kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2020-01-01 to 2020-12-31−$4.5mus-gaap:OperatingIncomeLoss
Net income12 months2020-01-01 to 2020-12-31−$5.0mus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-01-01 to 2020-12-31−$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2020-12-31$816.9kus-gaap:Cash
Current assetsAt period end2020-12-31$819.5kus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$1.3mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$7.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$7.9mus-gaap:Liabilities
Shareholders' equityAt period end2020-12-31−$6.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-21-005910. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.